Molecular Templates is a venture-backed biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics with advantages over existing Antibody Drug Conjugates (ADCs). This biologics platform technology can be used to develop different therapies across a wide range of cancers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/08/13 | $8,500,000 | Series C |
Excel Venture Management | undisclosed |
| 09/15/14 | $3,500,000 | Series C-1 |
AJU IB Investment | undisclosed |
